Computer Aided Detection of Polyps in Colonoscopy

November 29, 2021 updated by: Iterative Scopes, Inc

Randomized, Controlled Trial of a Computer Aided Detection Device in Standard Colonoscopy

The aim of this study is to evaluate the clinical benefit and safety of using a computer aided detection device, Skout, for real-time polyp detection in colonoscopy procedures with the indication of screening or surveillance. One of the reasons for the development of interval colorectal cancers is polyps missed during colonoscopy. Our hypothesis is that with the aid of Skout, the adenomas detected per colonoscopy will increase, and it is plausible to believe that this increase in detection could reduce the incidence of interval cancers.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

1472

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02114
        • Massachusetts General Hospital
      • Boston, Massachusetts, United States, 02118
        • Boston Medical Center
      • Cambridge, Massachusetts, United States, 02138
        • Mount Auburn Hospital
    • Minnesota
      • Plymouth, Minnesota, United States, 55446
        • MNGI Digestive Health
    • New Hampshire
      • Concord, New Hampshire, United States, 03301
        • Concord Endoscopy Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria

Participants will be eligible for this study if they are:

  • Undergoing colonoscopy with screening, surveillance, or diagnostic indications.
  • Undergoing a procedure by a participating endoscopist.
  • Have given informed consent.

Exclusion Criteria

Participants will not be eligible for this study if they:

  • Have a history of inflammatory bowel disease.
  • Have a history of familial adenomatous polyposis.
  • Are under the age of 40.
  • Have had a colonoscopy within the previous three (3) years.
  • Undergoing diagnostic colonoscopy with high-risk indications including iron deficiency anemia, abnormal CT imaging, unexplained weight loss, Lynch Syndrome, blood in stool or FIT positive test.
  • Entered with poor bowel preparation (inadequate for procedure as assessed by the Investigator).
  • Use anti-platelet agents or anticoagulants that preclude the removal of polyps during the procedure.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SCREENING
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: Control
Routine Colonoscopy
EXPERIMENTAL: Experimental
Routine Colonoscopy with the use of Skout
The Computer Aided Detection device, Skout, is designed to help endoscopists detect potential colorectal polyps during colonoscopies. The system performs automated real-time analysis on endoscopic video data to identify potential polyps and produces an informational visual aid around the appropriate sections of the video frames on a display monitor.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adenomas per colonoscopy
Time Frame: At the end of the procedure, 1 day
The total number of adenomas detected divided by the total number of colonoscopies.
At the end of the procedure, 1 day
Positive predictive value
Time Frame: At the end of the procedure, 1 day
The total number of adenomas and serrated lesions detected divided by the total number of extractions.
At the end of the procedure, 1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adenoma detection rate
Time Frame: At the end of the procedure, 1 day
The percentage of participants aged ≥50 years undergoing first-time screening colonoscopy who have one or more conventional adenomas detected.
At the end of the procedure, 1 day
Sessile serrated lesions detected
Time Frame: At the end of the procedure, 1 day
The total number of polyps with histology or serrated adenoma, traditional serrated adenoma or serrated lesion with cytological dysplasia, excluding hyperplastic polyps.
At the end of the procedure, 1 day
Colorectal cancer surveillance interval
Time Frame: At the end of the procedure, 1 day
The mean recommended timeframe for follow up colonoscopy.
At the end of the procedure, 1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Aasma Shaukat, MD, MPH, University of Minnesota

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 22, 2021

Primary Completion (ACTUAL)

October 31, 2021

Study Completion (ACTUAL)

October 31, 2021

Study Registration Dates

First Submitted

February 10, 2021

First Submitted That Met QC Criteria

February 10, 2021

First Posted (ACTUAL)

February 15, 2021

Study Record Updates

Last Update Posted (ACTUAL)

December 1, 2021

Last Update Submitted That Met QC Criteria

November 29, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colorectal Polyp

Clinical Trials on Computer Aided Detection device

3
Subscribe